Objectives
Recommendations and Clinical Guidelines in Rhinoplasty during COVID-19 pandemic
Introductory lecture
C-19 PCR and Antibody test | Parham Sendi
Panelists
Mario Bussi | Nazim Çerkes | Charles East | Olivier Gerbault | Wolfgang Gubisch | Haug Martin | Werner Heppt | Haldun Kamburoğlu | Philio Lekakis | Enrico Robotti
Guests
in collaboration with TRS (The Rhinoplasty Society US)
Jay Calvert USA | Sam Most USA | Rod Rohrich USA
Moderation
Martin Haug | Enrico Robotti
Organization
Martin Haug | Josef Vavrina
Program
20:00 Start and welcome (Enrico Robotti)
20:05-20:15 Prof Parham Sendi, lecture “C-19 PCR and Antibody test”.
20:15-20:23 Session 1: Protection during consultation with patients
Chair: Philio Lekakis
- Separate COVID-19 area in private practice?
- Which items work – masks, shields, air purifying systems, UV-C, disinfection?
- How to use them?
- Chest CT scan for screen or diagnosis?
20:23-20:30 Discussion, consensus conference with voting by expert panel, Q&A
20:30-20:40 Rod Rohrich “How do we handle this in Dallas and how the situation is seen and evolves in the US Plastic Surgery community”
20:40-20:50 Session 2: Patient assessment Pre-Op
Chair: Charles East
Patient selection, indication:
- Structured medical history: What are the key questions?
- Which patients should not undergo surgery?
- Which operations can/may/should be performed?
- Operation indications? (elective is not elective)
Testing:
- How to avoid operating on undetected COVID-19 patients
- Which PCR test?
- Are Antibody-tests useful at the moment?
Timing:
- How many days/hours before operation?
- Is quarantine necessary? Duration?
20:50-21:00 Discussion, consensus conference with voting by expert panel, Q&A
21:00-21:05 Sam Most “How do we handle this at Stanford and how the situation is seen and evolves in the US ENT community”
21:05-21:15 Session 3: Intra-Op
Chair: Werner Heppt, Olivier Gerbault
- Is an antiseptic packing prior to surgery of any use to reduce the viral charge?
- Intranasal/pharynx disinfection? How and which products?
- Does laminar flow protect us?
- How to protect ourselves?
- General anesthesia: Is there a difference?
- Aerosol in the OR: How to avoid production?
- Are there techniques/maneuvers to avoid? Power instruments ? Piezo?
- Nasal packing: How to handle?
21:15-21:25 Discussion, consensus conference with voting by expert panel, Q&A
21:25-21:30 Mario Bussi “Italian ENT Society and other European ENT Societies good practice perspectives regarding rhinoplasty in the COVID-19 era”
21:30-21:40 Jay Calvert “Performing rhinoplasty safely during the COVID-19 pandemic: a perspective from The Rhinoplasty Society US”
21:40-21:45 Rod Rohrich “Medical rhinoplasty and fillers: How should we approach it?”
21:45-21:50 Sam Most “Surviving COVID-19, perspectives from the other side: as a patient”
21:50-22:00 Session 4: Legal aspects, problems
Chair: Haldun Kamburoglu
- Does COVID-19 influence the rate of problems during surgery?
- How can a rhinoplasty patient be infected (consultation, operation, follow-up) and in which circumstances is the surgeon responsible?
- Is this a complication or malpractice?
- What is the correct timing for resuming elective surgery? Is it worth to take the risk? What should be the threshold – corona virus positive cases number in your city to feel safe?
- Do informed consent forms protect us?
- If any risk occurs, does your insurance policy cover it?
22:00 Discussion, consensus conference with voting by expert panel, Q&A
Conclusions by Martin Haug, Enrico Robotti